论文部分内容阅读
鉴于口服避孕药的妇女常伴有碳水化合物代谢的改变,并认为这一作用主要是与药物中的孕激素有关,为此作者前瞻调查了口服18甲-炔诺酮18个月前后的葡萄糖耐量试验,并测定了实验期间的血浆胰岛素水平。作者选择50名正常妇女为研究对象,平均年龄为21±0.7(岁),平均胎次为1.8±0.2(次),服药前平均体重为138.8±3.8(磅),服药18个月后为146.5±4.7(磅);她们或产后8周以上或停服甾体避孕药3个月以上。受试者试验前3天食用高糖
Given that oral contraceptives are often accompanied by changes in carbohydrate metabolism and that this effect is mainly related to the progestin in the drug, we prospectively investigated glucose tolerance 18 months after oral administration of 18-norethindrone Test, and measured plasma insulin levels during the experiment. The study selected 50 normal women as study subjects, with an average age of 21 ± 0.7 (years), an average parity of 1.8 ± 0.2 (subscript), an average body weight of 138.8 ± 3.8 (pounds) before taking and 146.5 after 18 months ± 4.7 (pounds); they or more than 8 weeks after delivery or stop taking steroid pills more than 3 months. Subjects consumed high glucose 3 days before the test